Treatment with deferasirox (Exjade) effectivel... [Br J Haematol. 2010] - PubMed

Save items

loading

Related citations in PubMed

Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia. [Br J Haematol. 2010]
Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia.
Ladis V, Berdousi H, Gotsis E, Kattamis A. Br J Haematol. 2010 Dec; 151(5):504-8. Epub 2010 Oct 18.
Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload. [Haematologica. 2011]
Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload.
Pennell DJ, Porter JB, Cappellini MD, Chan LL, El-Beshlawy A, Aydinok Y, Ibrahim H, Li CK, Viprakasit V, Elalfy MS, et al. Haematologica. 2011 Jan; 96(1):48-54. Epub 2010 Nov 11.
Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major. [Ann Hematol. 2010]
Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.
Pathare A, Taher A, Daar S. Ann Hematol. 2010 Apr; 89(4):405-9. Epub 2009 Oct 2.
Review Exjade (ICL 670): A new oral iron chelator. [J Assoc Physicians India. 2006]
Review Exjade (ICL 670): A new oral iron chelator.
Agarwal MB. J Assoc Physicians India. 2006 Mar; 54:214-7.
Review Current status of iron overload and chelation with deferasirox. [Indian J Pediatr. 2007]
Review Current status of iron overload and chelation with deferasirox.
Choudhry VP, Naithani R. Indian J Pediatr. 2007 Aug; 74(8):759-64.

See reviews... See all...

Cited by 1 PubMed Central article

Management of transfusional iron overload - differential properties and efficacy of iron chelating agents. [J Blood Med. 2011]
Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.
Kwiatkowski JL. J Blood Med. 2011; 2:135-49. Epub 2011 Sep 21.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Treatment with deferasirox (Exjade) effectively decreases iron burden in patient...
Treatment with deferasirox (Exjade) effectively decreases iron burden in patients with thalassaemia intermedia: results of a pilot study.
Br J Haematol. 2010 Jan ;148(2):332-4. Epub 2009 Oct 26 .

PubMed
Nutrition and bone: it is more than calcium and vitamin D.
Nutrition and bone: it is more than calcium and vitamin D.
Womens Health (Lond Engl). 2009 Nov ;5(6):727-37.

PubMed
Germline mutation screening of the Saethre-Chotzen-associated genes TWIST1 and F...
Germline mutation screening of the Saethre-Chotzen-associated genes TWIST1 and FGFR3 in families with BRCA1/2-negative breast cancer.
Scand J Plast Reconstr Surg Hand Surg. 2009 ;43(5):251-5.

PubMed
Intussusception and rotavirus vaccination: a review of the available evidence.
Intussusception and rotavirus vaccination: a review of the available evidence.
Expert Rev Vaccines. 2009 Nov ;8(11):1555-64.

PubMed
Multiple blood-proteins approach for early-response exposure assessment using an...
Multiple blood-proteins approach for early-response exposure assessment using an in vivo murine radiation model.
Int J Radiat Biol. 2009 ;85(10):837-50.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Treatment with deferasirox (Exjade) effectively decreases iron burden in patients with thalassaemia intermedia: results of a pilot study.

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information